L-Dopa and Parkinsonism.

Suppr

超能文献

作者信息

Calne D B, Sandler M

出版信息

Nature. 1970 Apr 4;226(5240):21-4. doi: 10.1038/226021a0.

DOI:10.1038/226021a0

PMID:4907560

Abstract

摘要

相似文献

L-Dopa and Parkinsonism.

Nature. 1970 Apr 4;226(5240):21-4. doi: 10.1038/226021a0.

L-Dopa in the treatment of parkinsonism.

Clin Pharmacol Ther. 1970 Nov-Dec;11(6):789-801. doi: 10.1002/cpt1970116789.

The pharmacology of parkinsonism (a review).帕金森病药理学（综述）

Dis Nerv Syst. 1968 Dec;29(12):805-16.

[Treatment of Parkinson's disease with L-dopa].[左旋多巴治疗帕金森病]

Clin Ter. 1970 May 15;53(3):259-69.

Theoretical implications of the use of L-dopa in parkinsonism. A review.左旋多巴在帕金森病治疗中的理论意义。综述。

Acta Neurol Scand. 1970;46(4):409-41. doi: 10.1111/j.1600-0404.1970.tb05804.x.

How does L-dopa work in parkinsonism?左旋多巴在帕金森病中是如何起作用的？

Lancet. 1971 Apr 17;1(7703):784. doi: 10.1016/s0140-6736(71)91219-0.

[Advantages of the combination therapy (L-Dopa and decarboxylase inhibitors) in parkinsonism].

Wien Med Wochenschr. 1972 Jun 17;122(25):369-71.

[Transmethylating activity in vitro in patients with parkinsonism before and after treatment with L-dopa].[帕金森病患者左旋多巴治疗前后的体外转甲基活性]

Acta Neurol (Napoli). 1971 Jan-Feb;26(1):41-5.

[Advances in the treatment of parkinsonism].

Neurol Neurochir Pol. 1972 Mar-Apr;6(2):275-80.

Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.纹状体黑质变性。左旋多巴治疗反应及其与病理和神经化学的相关性。

J Neurol Sci. 1973 Jul;19(3):275-86. doi: 10.1016/0022-510x(73)90091-9.

引用本文的文献

Study of autocorrelations and uncertainties applied to patients with Parkinson's disease.应用于帕金森病患者的自相关和不确定性研究。

Sci Rep. 2025 Mar 24;15(1):10068. doi: 10.1038/s41598-025-94252-2.

Targeting serum response factor (SRF) deactivates ΔFosB and mitigates Levodopa-induced dyskinesia in a mouse model of Parkinson's disease.靶向血清反应因子 (SRF) 可使 ΔFosB 失活，减轻帕金森病小鼠模型中左旋多巴诱导的运动障碍。

Gene Ther. 2024 Nov;31(11-12):614-624. doi: 10.1038/s41434-024-00492-8. Epub 2024 Oct 9.

The Dopaminergic Cells in the Median Raphe Region Regulate Social Behavior in Male Mice.中缝正中区的多巴胺能细胞调节雄性小鼠的社会行为。

Int J Mol Sci. 2024 Apr 13;25(8):4315. doi: 10.3390/ijms25084315.

Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases.环境与基因与肥胖的关联及其对神经退行性疾病和神经发育疾病的影响。

Front Neurosci. 2020 Aug 28;14:863. doi: 10.3389/fnins.2020.00863. eCollection 2020.

Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders.血脑屏障：在神经系统疾病中，对中枢神经系统稳态破坏的促成作用大于受害者。

Front Neurosci. 2020 Aug 6;14:764. doi: 10.3389/fnins.2020.00764. eCollection 2020.

Cocaine‑ and amphetamine‑regulated transcript (CART) is associated with dopamine and is protective against ischemic stroke.可卡因和苯丙胺调节转录物（CART）与多巴胺有关，可预防缺血性中风。

Mol Med Rep. 2018 Sep;18(3):3298-3304. doi: 10.3892/mmr.2018.9296. Epub 2018 Jul 19.

Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.不良结局途径：应用于增强神经毒性的机制理解

Pharmacol Ther. 2017 Nov;179:84-95. doi: 10.1016/j.pharmthera.2017.05.006. Epub 2017 May 18.

Levodopa in Mucuna pruriens and its degradation.刺蒺藜中的左旋多巴及其降解

Sci Rep. 2015 Jun 9;5:11078. doi: 10.1038/srep11078.

Effect of chronic neuroleptic treatment on central and peripheral muscarinic receptors.长期使用抗精神病药物治疗对中枢和外周毒蕈碱受体的影响。

J Pharmacol Exp Ther. 1993 Oct;267(1):134-9.

1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.1-羟基-3-氨基吡咯烷-2（HA-966）：一种新型γ-氨基丁酸样化合物，在锥体外系疾病中具有潜在应用价值。

Br J Pharmacol. 1971 Nov;43(3):514-35. doi: 10.1111/j.1476-5381.1971.tb07182.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验